RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Simulations Plus - Stock

Simulations Plus P/E 2024

Simulations Plus P/E

78.63

Ticker

SLP

ISIN

US8292141053

WKN

924294

As of Jul 1, 2024, Simulations Plus's P/E ratio was 78.63, a -16.74% change from the 94.44 P/E ratio recorded in the previous year.

The Simulations Plus P/E history

Simulations Plus Aktienanalyse

What does Simulations Plus do?

Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health. The translation of the text is: "Simulations Plus Inc is a company that offers software and services for the pharmaceutical industry. The company was founded in 1996 by Dr. Walt Woltosz and is headquartered in Lancaster, California. Simulations Plus began with the development of GastroPlus, a software that simulates the effects of drugs in the body using mathematical models. This software quickly became an important tool for the pharmaceutical industry to improve the effectiveness and safety of medications. Simulations Plus's business model is based on providing high-quality software and services for the pharmaceutical industry. They offer a wide range of products aimed at improving the effectiveness and safety of drugs by optimizing drug development and design. These products include software for simulating and analyzing the pharmacokinetics and dynamics of medications, a model for detecting and avoiding potential life-threatening liver damage, a cloud-based platform for simplifying the work of scientists and researchers, and services to assist with regulatory affairs and obtaining product approvals. Simulations Plus is known for its high-quality products and excellent customer support, and their various divisions and products contribute to improving the effectiveness and safety of medications, ultimately promoting patient health." Simulations Plus ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Simulations Plus's P/E Ratio

The Price to Earnings (P/E) Ratio of Simulations Plus is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Simulations Plus's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Simulations Plus is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Simulations Plus’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Simulations Plus Stock

What is the price-to-earnings ratio of Simulations Plus?

The price-earnings ratio of Simulations Plus is currently 78.63.

How has the price-earnings ratio of Simulations Plus changed compared to last year?

The price-to-earnings ratio of Simulations Plus has increased by -16.74% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Simulations Plus high compared to other companies?

Yes, the price-to-earnings ratio of Simulations Plus is high compared to other companies.

How does an increase in the price-earnings ratio of Simulations Plus affect the company?

An increase in the price-earnings ratio of Simulations Plus would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Simulations Plus affect the company?

A decrease in the price-earnings ratio of Simulations Plus would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Simulations Plus?

Some factors that influence the price-earnings ratio of Simulations Plus are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Simulations Plus pay?

Over the past 12 months, Simulations Plus paid a dividend of 0.24 USD . This corresponds to a dividend yield of about 0.49 %. For the coming 12 months, Simulations Plus is expected to pay a dividend of 0.25 USD.

What is the dividend yield of Simulations Plus?

The current dividend yield of Simulations Plus is 0.49 %.

When does Simulations Plus pay dividends?

Simulations Plus pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of Simulations Plus?

Simulations Plus paid dividends every year for the past 0 years.

What is the dividend of Simulations Plus?

For the upcoming 12 months, dividends amounting to 0.25 USD are expected. This corresponds to a dividend yield of 0.51 %.

In which sector is Simulations Plus located?

Simulations Plus is assigned to the 'Health' sector.

Wann musste ich die Aktien von Simulations Plus kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Simulations Plus from 5/6/2024 amounting to 0.06 USD, you needed to have the stock in your portfolio before the ex-date on 4/26/2024.

When did Simulations Plus pay the last dividend?

The last dividend was paid out on 5/6/2024.

What was the dividend of Simulations Plus in the year 2023?

In the year 2023, Simulations Plus distributed 0.24 USD as dividends.

In which currency does Simulations Plus pay out the dividend?

The dividends of Simulations Plus are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Simulations Plus

Our stock analysis for Simulations Plus Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Simulations Plus Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.